Endoscopic submucosal dissection (ESD) is an organ-preserving surgery performed for en bloc resection of pre-cancerous and early cancerous gastrointestinal (GI) lesions with a curative intent.1 It has been performed in Japan since the 1990s and is now increasingly acquired by Western countries for management of early GI cancers.
Full article available to subscribers
Endoscopic submucosal dissection (ESD) is an organ-preserving surgery performed for en bloc resection of pre-cancerous and early cancerous gastrointestinal (GI) lesions with a curative intent.1 It has been performed in Japan since the 1990s and is now increasingly acquired by Western countries for management of early GI cancers.2 It allows en bloc resection of the lesions and higher rates of R0 resection (clear vertical and radial margins histopathologically), which may result in curative resection of these cancers and preclude need for radical surgery or any other additional treatment.3
There is no structured programme for training in ESD in New Zealand. There is no screening programme for detection of early gastric cancer in New Zealand, which is considered an ideal target for commencement of ESD training. There is also a higher risk of complications with ESD in comparison to endoscopic mucosal resection (EMR). These factors have contributed to poor uptake of ESD in New Zealand and in Western countries in general.4
Studies from high-volume Japanese centres with a structured training programme with availability of gastric lesions suggest early ESD proficiency is acquired after 30–40 procedures; however, in a Western setting with much lower volumes, achieving the same number of procedures in the setting of unstructured training is usually not possible.5,6 Data from Western countries show that dissection speed and en bloc resection rates continuously improve during the course of 40 to more than 100 procedures.4,7–9
The aim of this study is to assess the learning curve of ESD applicable to the New Zealand setting where ESD is currently performed untutored. This study can serve as a useful guide to devise a training programme for ESD in New Zealand.
A prospective database of all ESD procedures is maintained at Middlemore Hospital, a tertiary referral centre in Auckland, New Zealand. We retrospectively analysed the outcomes for all consecutive ESD procedures performed by a single endoscopist (AS) over a 4-year period from February 2019 to January 2023. We captured patient demographics, location of the ESD, specimen size, en bloc resection rates, R0 resection rates, dissection speed and complications. We analysed the learning curve using the accepted international benchmarks.
All cases put forward to undergo ESD were discussed at a multidisciplinary meeting (MDM). The majority of cases were referred with intent of curative resection; however, some cases were referred for staging, rather than for curative intent. These were cases with unclear level of invasion on imaging but suspected, based on endoscopic appearances, to be beyond cure with ESD.
The operator had 7 years’ experience of performing extensive endoscopic mucosal resection throughout the GI tract. Preclinical training for ESD included the operator observing approximately 10 live cases of ESD being performed by Japanese and European experts. Following this, ESD was practised in ex vivo models (approximately 8 hours) and live porcine models (approximately 20 hours). The operator also watched more than 100 hours of ESD case videos in entirety performed by Japanese experts.
The first ESD procedure was carried out in February 2019. Each ESD procedure was videoed in its entirety. The first 15 cases were sent to local expert in ESD (CS), who reviewed each case and provided feedback directly to the operator after each ESD.
Procedures were undertaken using either conscious sedation with fentanyl and midazolam or under general anaesthesia. Oesophageal and gastric lesions were marked prior to ESD and lifted with standard lifting solutions. Colorectal lesions were not marked and were lifted with standard lifting solution. ESD was performed using DualKnife J (Olympus America). The ESD bed was examined carefully post-procedure and haemostasis was achieved with thermal coagulation using the knife or coagulation graspers. Intraoperative perforation was closed using either standard clips or over-the-scope clip (Ovesco OTSC®).
En bloc resection was defined as removal of the lesion in a single piece. For carcinomas, R0 resection was defined as a resection specimen with radial and deep margins clear of dysplasia or cancer, while R1 was defined as a specimen with presence of dysplasia or cancer at the margin. A curative resection was defined as per European Society of Gastrointestinal Endoscopy guidelines.10 For non-cancerous lesions R0 resection was considered curative. For cancerous lesions the definition of a curative resection was more complex, defined as R0 with absence of vascular and lymphatic involvement, low tumour budding and a varying limit of depth of invasion according to the location and histology of the lesion. For oesophageal squamous cell carcinoma (SCC) the depth of invasion deemed to be curative was <200 μm from muscularis mucosa, for oesophageal or gastric adenocarcinoma the depth of invasion deemed to be curative was <500 μm from muscularis mucosa and for colorectal adenocarcinoma the depth of invasion deemed to be curative was <1000 μm from muscularis mucosa.10
Each ESD specimen was pinned to a corkboard, placed in formalin, processed and then reviewed by a specialised GI pathologist (MY). Histology was reported with assessment of radial and deep margins for all lesions to determine whether the resection met R0 criteria. In the case of a cancer, depth of invasion of cancer was reported from muscularis mucosae along with tumour budding, cancer grade based on differentiation and presence or absence of lymphovascular invasion. Lesions were considered curative as per the definitions used for curative resection as above. All histology results were reviewed in an MDM.
Categorical data were presented as counts and proportions while continuous data were presented as means and standard deviations. We chose the internationally accepted benchmarks of dissection speed ≥9cm2/h, ≥90% en bloc resection rate and ≥80% R0 resection rate as markers to assess the proficiency of the ESD operator.11
ESD duration (in hours) was estimated as the time between submucosal injection and specimen retrieval, and dissection speed was estimated as dissection lesion size (in cm2) divided by ESD duration. The average dissection speed for sequential 20-case blocks was calculated, and the trend was shown by using a 20-case moving average graph. In addition, the rates of en bloc resection and R0 resection were further calculated for sequential 20-case blocks. A cohort bar plot was used to visualise average speed per case block and rates of en bloc and R0 resections in comparison with the internationally accepted benchmark speed in different organs and case blocks. Furthermore, the Mann–Kendall test was implemented using trend R package in order to determine whether or not, overall, there was a monotonic trend in the dissection speed of the single operator.12 R programming language version 4.3.1 was used to carry out these analyses.13
We retrospectively analysed the outcomes for 80 ESD procedures performed by a single endoscopist over a 4-year period. The average age of patients undergoing ESD was 68 years and 67.5% of our patients were male. The majority of patients were NZ European (57.5%), 15% were Asian, 16.25% were Pacific peoples and 5% were Māori (Table 1).
View Table 1, Figure 1–7.
The 80 cases comprised 6 oesophageal, 20 gastric, 18 colonic and 36 rectal lesions (Figure 1).
Adenocarcinoma comprised 25% of the cases (20 patients), with most of the remaining cases being made up of tubulovillous adenomas with low-grade dysplasia (18.8%, 15 cases) and tubular adenomas with low-grade dysplasia (18.8%, 15 cases). There were two cases (2.5%) of tubular adenomas with high-grade dysplasia and four (5%) cases of tubulovillous adenoma with high-grade dysplasia. There were small numbers of oesophageal SCC in situ, enterochromaffin-like (ECL) cell hyperplasia, serrated adenomas, hyperplastic polyps and sessile serrated adenoma with dysplasia (SSAD) (Figure 2).
Our results have shown that average dissection speed increased sequentially as experience improved. This became statistically significant (p=0.00002) after 60 procedures and extended beyond the international benchmark in the 61–80 case sequential block (Figure 3). The moving average of dissection speed improved over time as the operator gained more experience (Figure 4).
The speed of dissection greatly varied between organs, with the fastest dissection speed being in colorectal lesions (Figure 5). This may be attributed to the fact that two thirds of the lesions were colorectal, with more experience in treating these lesions potentially resulting in faster dissection speed.
En bloc resection was possible in 88.7% of cases (71 out of 80 cases). In the remainder of cases, ESD was converted to EMR to achieve full resection of the lesion. R0 resection was achieved in 72.5% of cases (58 out of 80 cases). A curative rate of 67.5% was achieved (54 out of 80 cases). There were several cases that were undertaken for staging purposes rather than curative intent, but these data were not captured prospectively.
The en bloc resection rates achieved proficient level by the end of our series to above 90%. R0 resection rates met the international benchmark of 80% by the second block of 20 but dropped below this in the last two sequential blocks (Figure 6). This could be due to the fact the lesion size steadily increased (p=0.002) over 80 cases (Figure 7), more challenging cases were accepted for ESD, an increasing number of cases were accepted for staging purposes, or a combination of the aforementioned.
There was a perforation rate of 6.25% (five patients). Four of the perforations were recognised intraoperatively and closed with standard clips, received intravenous antibiotics and required no further intervention. One patient (1.25%) required emergency surgery for an unrecognised rectal perforation, undergoing a low anterior resection with a length of stay of 9 days. One patient (1.25%) had delayed bleeding requiring three units of blood but no endoscopic or surgical intervention. One patient (1.25%) had oesophageal stricturing after a circumferential oesophageal ESD, managed with serial dilatations. Two patients had post-ESD inflammatory syndrome and were managed with antibiotics.
Eighteen patients (22.5%) were admitted to the hospital for observation after ESD for a mean of 2.3 days (range 1–9 days). There were no deaths in our cohort.
This study demonstrates feasibility, efficacy and safety of an untutored, prevalence-based approach of a single operator. The slow uptake of ESD in the West, despite the advantages it offers over EMR, has been attributed to a lack of structured training programmes, a lack of suitable target lesions and a higher risk of complications with ESD.4 Many Asian countries such as Japan, on the other hand, have structured training programmes where trainees perform ESD under expert supervision, as well as an abundance of gastric lesions that are recognised as more suitable lesions for the initial learning curve of ESD due to the improved accessibility and thickness of the stomach layer.14 Consequently, proficiency in ESD in Western countries must be attained in an alternative fashion, as these settings are unable to provide the same environs available in countries such as Japan. A recent meta-analysis showed that en bloc and R0 resection rates in the Eastern studies were significantly higher at 95% and 89% respectively compared to Western studies where it dropped to 85% and 74% respectively. The percentage of perforations requiring surgery was significantly greater in Western countries (0.53%) compared to Eastern countries (0.01%). ESD procedure times were longer in Western countries (110 min vs 77 min).15
In most Japanese centres, trainees begin ESD on gastric lesions. Oda et al. showed that 30 cases in the stomach were sufficient to gain competence in a supervised, tutored setting.5 The learning curve to achieve proficiency in colorectal ESD has been demonstrated. However, most operators in these studies had a prior experience of gastric ESD.9 Forty colorectal ESDs were required to gain competence with prior experience of gastric ESD. A study from Korea evaluated colorectal ESD training without prior experience in gastric ESD in a supervised setting. This study suggests that more than 100 cases are required to gain competence.16
These data, however, cannot be as readily applied to New Zealand, as there is no supervised training and the cases referred are a mix of oesophageal, gastric and colorectal lesions. Thus, an untutored prevalence-based approach is more realistic and pragmatic. Similar issues have been encountered in Europe and America. Untutored learning of ESD in Europe was first reported by Berr et al. performing ESD with a prevalence-based approach.17 The en bloc resection in the 50 cases evaluated in this study was 76%. Recent data from the US have shown that approximately 250 procedures are required to attain all parameters for ESD proficiency in all organs in an untutored, prevalence-based approach.4
We achieved the international benchmark of proficiency of en bloc resection rates and dissection speed with our ESD cohort. R0 resection rates are still below proficiency level; however, they are consistent with reported R0 resection rates at this level of ESD experience in Western studies.18 Our R0 resection rates may have been lower due to acceptance of more complex cases, larger size of the lesions in the latter part of the study and, in particular, cases accepted for staging where R0 resection is not an expectation.
Our complication rates were similar to those reported Western studies but higher than studies from Japan.19 This may be attributable to our prevalence-based approach rather than gradual progression of easier gastric antrum lesions to more difficult lesions.
The strength of this study is that it demonstrates a real-world picture of the ESD learning curve in New Zealand. The prevalence-based approach is employed due to the case mix with variable lesion location and pathology, previously manipulated lesions and lack of supervision. Despite this, proficiency can be achieved safely with acceptable complication rates.
One of the limitations of our study is that it highlights the experience of a single endoscopist and may not translate to other endoscopists due to variability of technical skills and previous experience in advanced endoscopy. Nevertheless, similar models in Western studies have reported similar results.4,19 Regardless, it is likely that most larger centres in New Zealand will have only a few endoscopists who will take up ESD due to limited cases and this study will be generalisable to these centres.
Our study shows that there is a learning curve in ESD, with consistent improvement in dissection speed and en bloc resection rates in an untutored prevalence-based setting. Proficiency in ESD in most aspects can be achieved after 80 cases and is not site-specific. Higher numbers of ESD and careful lesion selection are required to reach the international benchmark for proficiency in R0 resection.
Finally, these data can help design the training programmes for ESD in centres where a prevalence-based approach is necessary.
Endoscopic submucosal dissection (ESD) is a specialised endoscopic technique in the treatment of large pre-cancerous and early cancerous gastrointestinal lesions that avoids the need for surgical resections. The objective of this study was to assess the feasibility, efficacy and safety of learning ESD in an untutored approach in a prevalence-based setting within New Zealand.
Over a 4-year period, 80 ESD procedures were performed at a single tertiary centre within New Zealand. We retrospectively reviewed basic demographics of the patients, along with successful en bloc resection rates, dissection speeds, histological diagnoses (including margin assessments) and complications.
We captured 80 procedures. Within this database we achieved an en bloc resection of 88.7% (71 out of 80 cases) and an R0 resection of 72.5% (58 out of 80 cases). The international benchmark for dissection speed of 9cm2/h was achieved within the first block of 20 cases and was maintained throughout. There was a perforation rate of 6.25% (five patients), with one patient (1.25%) requiring emergency surgery for a rectal perforation.
Our study shows it is feasible and safe to learn ESD within a low-volume tertiary centre within New Zealand via a prevalence-based approached. The majority of patients were able to have en bloc resection and a R0 resection. Our intent is that this data be used to help design a more formalised training process for learning ESD within a New Zealand setting.
Tara Fox: Department of Gastroenterology, Middlemore Hospital, Auckland.
Masato Yozu: Histopathology Department, Middlemore Hospital, Auckland.
Sze-Lin Peng: Department of General Surgery, Middlemore Hospital, Auckland.
Cameron Schauer: Department of Gastroenterology, North Shore Hospital, Auckland.
Anurag Sekra: Department of Gastroenterology, Middlemore Hospital, Auckland.
Anurag Sekra: Department of Gastroenterology, Middlemore Hospital, Auckland.
Nil.
1) Kakushima N, Fujishiro M. Endoscopic submucosal dissection for gastrointestinal neoplasms. World J Gastroenterol. 2008 May 21;14(19):2962-7. doi: 10.3748/wjg.14.2962.
2) Friedel D, Stavropoulos SN. Introduction of endoscopic submucosal dissection in the West. World J Gastrointest Endosc. 2018 Oct 16;10(10):225-38. doi: 10.4253/wjge.v10.i10.225.
3) Bhatt A, Abe S, Kumaravel A, et al. Indications and Techniques for Endoscopic Submucosal Dissection. Am J Gastroenterol. 2015 Jun;110(6):784-91. doi: 10.1038/ajg.2014.425.
4) Zhang X, Ly EK, Nithyanand S, et al. Learning Curve for Endoscopic Submucosal Dissection With an Untutored, Prevalence-Based Approach in the United States. Clin Gastroenterol Hepatol. 2020 Mar;18(3):580-588.e1. doi: 10.1016/j.cgh.2019.06.008.
5) Oda I, Odagaki T, Suzuki H, et al. Learning curve for endoscopic submucosal dissection of early gastric cancer based on trainee experience. Dig Endosc. 2012 May 25;24 Suppl 1:129-32. doi: 10.1111/j.1443-1661.2012.01265.x.
6) Yamamoto Y, Fujisaki J, Ishiyama A, et al. Current status of training for endoscopic submucosal dissection for gastric epithelial neoplasm at Cancer Institute Hospital, Japanese Foundation For Cancer Research, a famous Japanese hospital. Dig Endosc. 2012 May 25;24 Suppl 1:148-53. doi: 10.1111/j.1443-1661.2012.01278.x.
7) Kakushima N, Fujishiro M, Kodashima S, et al. A learning curve for endoscopic submucosal dissection of gastric epithelial neoplasms. Endoscopy. 2006 Oct 20;38(10):991-5. doi: 10.1055/s-2006-944808.
8) Probst A, Golger D, Anthuber M, et al. Endoscopic submucosal dissection in large sessile lesions of the rectosigmoid: learning curve in a European center. Endoscopy. 2012 Jul 23;44(7):660-7. doi: 10.1055/s-0032-1309403.
9) Sakamoto T, Saito Y, Fukunaga S, et al. Learning curve associated with colorectal endoscopic submucosal dissection for endoscopists experienced in gastric endoscopic submucosal dissection. Dis Colon Rectum. 2011 Oct;54(10):1307-12. doi: 10.1097/DCR.0b013e3182282ab0.
10) Pimentel-Nunes P, Dinis-Ribeiro M, Ponchon T, et al. Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2015 Aug 28;47(9):829-54. doi: 10.1055/s-0034-1392882.
11) Oyama T, Yahagi N, Ponchon T, et al. How to establish endoscopic submucosal dissection in Western countries. World J Gastroenterol. 2015;21(40):11209-20. doi: 10.3748/wjg.v21.i40.11209.
12) Pohlert T. Non-Parametric Trend Tests and Change-Point Detection [Internet]. 2023 Oct 10 [cited 2024 Feb]. Available from: https://cran.r-project.org/web/packages/trend/vignettes/trend.pdf
13) Pohlert T, RD team. Package ‘trend’ [Internet]. 2023 Oct 10 [cited 2024 Feb]. Available from: https://cloud.r-project.org/web/packages/trend/trend.pdf
14) Uraoka T, Parra‐Blanco A, Yahagi N. Colorectal endoscopic submucosal dissection: Is it suitable in western countries? J Gastroenterol Hepatol. 2013 Mar 26;28(3):406-14. doi: 10.1111/jgh.12099.
15) Daoud DC, Suter N, Durand M, et al. Comparing outcomes for endoscopic submucosal dissection between Eastern and Western countries: A systematic review and meta-analysis. World J Gastroenterol. 2018 Jun 21;24(23):2518-36. doi: 10.3748/wjg.v24.i23.2518.
16) Yang DH, Jeong GH, Song Y, et al. The Feasibility of Performing Colorectal Endoscopic Submucosal Dissection Without Previous Experience in Performing Gastric Endoscopic Submucosal Dissection. Dig Dis Sci. 2015 Nov 19;60(11):3431-41. doi: 10.1007/s10620-015-3755-0.
17) Berr F, Wagner A, Kiesslich T, et al. Untutored learning curve to establish endoscopic submucosal dissection on competence level. Digestion. 2014;89(3):184-93. doi: 10.1159/000357805.
18) Probst A, Golger D, Arnholdt H, Messmann H. Endoscopic submucosal dissection of early cancers, flat adenomas, and submucosal tumors in the gastrointestinal tract. Clin Gastroenterol Hepatol. 2009 Feb;7(2):149-55. doi: 10.1016/j.cgh.2008.09.005.
19) Fleischmann C, Probst A, Ebigbo A, et al. Endoscopic Submucosal Dissection in Europe: Results of 1000 Neoplastic Lesions From the German Endoscopic Submucosal Dissection Registry. Gastroenterology. 2021 Oct;161(4):1168-78. doi: 10.1053/j.gastro.2021.06.049.
Sign in to view your account and access
the latest publications by the NZMJ.
Don't have an account?
Let's get started with creating an account.
Already have an account?
Become a member to enjoy unlimited digital access and support the ongoing publication of the New Zealand Medical Journal.
The New Zealand Medical Journal is fully available to individual subscribers and does not incur a subscription fee. This applies to both New Zealand and international subscribers. Institutions are encouraged to subscribe. The value of institutional subscriptions is essential to the NZMJ, as supporting a reputable medical journal demonstrates an institution’s commitment to academic excellence and professional development. By continuing to pay for a subscription, institutions signal their support for valuable medical research and contribute to the journal's continued success.
Please email us at nzmj@pmagroup.co.nz